Drug Repurposing ‘Fast Track’ to New Medicines for Obesity, Diabetes

Researchers have developed a computer program to identify drugs for other diseases that could be repurposed…

High PSMA Predicts Targeted Therapy Response in Prostate Cancer

BARCELONA — High levels of prostate-specific membrane antigen (PSMA) on whole-body positron emission tomography (PET) scans…

Lilian Gien, MD, Reviews Pembrolizumab Plus Epacadostat in Recurrent Clear Cell Carcinoma of the Ovary

During the 2022 Global Annual Meeting of the International Gynecologic Cancer SocietyCancerNetwork® spoke to Lilian Gien,…

Certain Patients With Cured HCV Still Face Risks for HCC

In patients with cured hepatitis C, the risk of hepatocellular carcinoma remains high in those who…

Pembrolizumab in Combination with Lenvatinib as First-Line Treatment for Non Clear Cell Renal Cell Carcinoma (nccRCC), KEYNOTE-B61

Read the full video transcript Pedro Barata: Hello and welcome. My name is Pedro Barata. I…